Navigation Links
Thompson MIS Wins a Best New Technology in Spine Care 2011 Award
Date:11/8/2011

SALEM, N.H., Nov. 8, 2011 /PRNewswire/ -- Thompson MIS is pleased to announce its BoneBac™ Press autograft collection system has received a "Best New Technology for Spine Care in 2011" award by Orthopedics This Week.  The award was presented to the company during the annual meeting of the North American Spine Society.

The reusable BoneBac™ Press is a patented system that enables surgeons to more effectively utilize local autograft bone for use in fusion and reconstructive procedures.  Graft shavings created during decompression that would normally be discarded are captured and separated from excess fluids.  It produces a condensed puck of autograft with ideal handling characteristics.  The BoneBac™ Press is an element of the BoneBac™ System, which was developed to simplify minimally invasive spine surgery and reduce procedure costs.

Orthopedics This Week and RRY Publications present the Spine Technology Awards event at an annual gala intended to raise awareness of innovative technologies and their development teams.  An independent panel of distinguished surgeons judges the technologies.  

About Thompson MIS:

Fusing technique and technology, Thompson MIS is a medical device company focused on minimally invasive spine surgery and instrumentation. Through the advancement of minimally invasive technologies and techniques, we are dedicated to improving outcomes for patients, enabling surgeon excellence, and reducing healthcare costs. Thompson MIS embraces the changes presented by the future of medicine and pledges to identify physician and patient needs and provide unsurpassed, innovative solutions.

Contact:

Thompson MIS
Corporate Communications
Phone: 888-932-6949
Email: info@thompsonmis.com
URL: www.thompsonmis.com


'/>"/>
SOURCE Thompson MIS
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ReShape Medical Names Richard Thompson President and Chief Executive Officer
2. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
3. Thompson Group Acquires Hamilton Sundstrands Applied Instrument Technologies
4. BayCare Health System Names Tim Thompson Chief Information Officer
5. ECRI Institute Announces its Top 10 Health Technology Hazards for 2012
6. Passion for Patient Care Marks 2011 National Radiologic Technology Week®
7. Ansell Extends Success of AMT Antimicrobial Technology for Surgical Gloves With Introduction in Europe
8. Bayer HealthCares MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT
9. Palos Offers New Technology in the Fight Against Breast Cancer
10. Australias Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elektas Advanced 4D Motion Management Technology
11. Arnold Palmer Hospital is First to Receive New FDA-Approved X-ray Imaging Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 /CNW/ - ... being recalled after Health Canada tests confirmed it contains ... risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health Distribution ... the product from retail stores across Canada ... purposes, including for weight loss and increased energy. ...
(Date:12/24/2014)... 2014  Novastem, a leader in regenerative medicine, ... its study for ischemic stroke at Clinica Santa ... strokes account for 87 percent of all stroke ... the study, entitled "Internal Research Protocol in Combination ... Cells and Intrathecal Administration of Neural Stem Cells ...
(Date:12/24/2014)... , Dec. 24, 2014  Actavis plc (NYSE: ... Company has received a complete response letter from ... its New Drug Application (NDA) for the fixed-dose ... treatment of hypertension.   Photo - ... disappointed in the receipt of a complete response ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
... , ATLANTA, Nov. 30 Amoena USA Corporation, ... the 4th Annual Breast Cancer Survivors Cruise. In 2010, for ... who helped them through their recovery by awarding a cabin ... , As part of the contest, Amoena wants to hear ...
... , ... the world,s leading research and advisory firms focusing on pharmaceutical ... market in Russia will grow nine percent annually over the ... This growth will be driven mainly by increased government spending ...
Cached Medicine Technology:Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3
(Date:12/25/2014)... This is a professional and in-depth ... industry with a focus on the Chinese market. The ... the Sterilizers manufacturers and is a valuable source of ... the industry. This report provides a basic overview of ... In this part, the report presents the company profile, ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The report ... 2023” focuses on the current treatment landscape, unmet needs, ... market. TS-1 is an anti-cancer drug which is typically ... and is also used for treating gastric cancer and ... otastat potassium. The drug was first approved in 1999 ...
(Date:12/25/2014)... December 25, 2014 Product liability lawsuits ... hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward ... an Order issued in the U.S. District Court, Northern ... convene an open conference on January 7, 2015, at ... Courthouse in West Palm Beach, Florida. The Conference is ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3
... Year DUSA Has Been Recognized , WILMINGTON, Mass., ... ), a specialty pharmaceutical company focused on dermatology, announced ... Fast 500 list. For the second consecutive year, ... fastest growing technology, media, telecommunications and life sciences companies ...
... MINNEAPOLIS, Oct. 21 For a sample of ... there are key terms one is suggested to start on: ... Premarin; Progesterone; SHBG; vitamin D. , Some will be covered ... deliver the keynote ,An Oncologist View of Hormones and Breast ...
... Dr. ... This device is able to measure internal temperature during laser liposuction. This increases ... ... certified plastic surgeon, is the first in St. Louis, MIssouri to use the Sciton TempAssure. ...
... ... medical malpractice insurance premium rates for every major insurer in every county in every ... year; declined in some instances , ... Chicago, IL (PRWEB) October 21, 2009 -- Rates for physicians, 2009-2010 ...
... Berg Injury Lawyers to cover ... ... the most dangerous nights of the year to be on the road because of drunk drivers. ... Friday, Saturday, or Sunday. , , , , ,To help reduce these accidents, Berg Injury Lawyers ...
... The rising cost of corporate healthcare is fast becoming a ... assessment by our health minister, Mr. Khaw Boon Wan, healthcare ... GDP to nearly 10 percent, and when that happens, it ... percent of their income on medical expenses alone. While the ...
Cached Medicine News:Health News:DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America 2Health News:DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America 3Health News:Bioidentical Hormones, a True Prevention for Breast Cancer 2Health News:Medical Liability Monitor Annual Survey of Medical Malpractice Insurance Rates Shows Medical Liability Insurance Market Remains Soft 2Health News:Drunk Drivers Scarier Than Ghosts and Goblins This Halloween 2Health News:Drunk Drivers Scarier Than Ghosts and Goblins This Halloween 3Health News:Breaking Through Corporate Health Frontiers 2Health News:Breaking Through Corporate Health Frontiers 3
0.3% Yeast Extract, 0.3% Malt Extract, 0.5% Peptone, and 1.0% Glucose....
1.7% Tryptone, 0.3% Soytone, 0.5% Sodium Chloride, 0.25% Dextrose, 0.25% Potassium Phosphate....
... Eppendorf Thermomixer R offers maximum application ... shaking, heating, and cooling. Its active ... application and temperature control ranges. Five ... 24 micro test tubes, are available ...
... 10k units Pen.,10k ug Strept. ... Cell Culture Reagent and Buffer ... with cGMP regulations and are ... compatibility. , Typical Properties, Sterility ...
Medicine Products: